At the January Democratic debate, Vermont Sen. Bernie Sanders zeroed in on the question of profits in the health care industry.
Under “Medicare for All,” he said, “we end the $100 billion a year that the health care industry makes.”
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
A daylong conference devoted to health care policy, coverage and care in Oregon this week ended with a discussion of the elephant in the room: the price of care.
The United States spends too much on health care, gets too little and throws billions away.
Before his double lung transplant, Tom Saputo thought he had anticipated every possible outcome.
But after the surgery, he wasn’t prepared for the price of the 27-mile air ambulance flight to UCLA Medical Center — which cost more than the lifesaving operation itself.
When Dr. Worta McCaskill-Stevens made an appointment for a mammogram last year, she expected a simple breast cancer screening ― not a heavy-handed sales pitch.
A receptionist asked if she wanted a free upgrade to a “3D mammogram,” or tomosynthesis.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Oregon is taking its first steps to build a regulatory system it hopes will curb the incessant, rapid rise in health care costs.
As voters fume about the high cost of health care, politicians have been targeting two well-deserved villains: pharmaceutical companies, whose prices have risen more than inflation, and ins
EASTON, Pa. — Walk into a big-box retailer such as Walmart or Michaels and you’re likely to see MCS Industries’ picture frames, decorative mirrors or kitschy wall décor.
Private health insurance plans in 2017 paid more than twice what Medicare would have for those same health care services, says a sweeping new study from Rand Corp., a respected research organization.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
A legislative task force has taken a crack at attacking rising health care costs.
The pharmaceutical industry could see windfall profits from a little-noticed tweak to the insurance market tucked into the Trump administration’s draft executive order on drug prices, experts say.
